Hephaistos

Hephaistos, based in Switzerland, excels in manufacturing innovative enzymes for sustainable production in the fine chemicals sector, utilizing advanced protein engineering and machine learning technologies. Hephaistos is a biotechnology firm founded in 2025 in Basel, Switzerland. The company focuses on developing enzymes for the fine chemicals industry, enhancing manufacturing processes through biocatalysis. In June 2026, Hephaistos secured CHF 150,000 in funding from Venture Kick to support further enzyme development.

The company has engaged in a single funding round to date, reflecting its commitment to innovation and growth. Hephaistos specializes in the development of novel enzymes tailored for sustainable manufacturing in the fine chemicals sector. The company leverages advanced protein engineering tools and machine learning algorithms to create custom enzymes capable of catalyzing specific chemical reactions currently unattainable with existing biocatalysis methods. These enzymes are designed from the ground up to meet the particular challenges faced by various industries, thereby enhancing production efficiency and reducing costs.

Hephaistos serves a diverse clientele that includes manufacturers and businesses involved in the synthesis of fine chemicals, totaling approximately 1. 47 million tons annually. While the company's products primarily cater to European and North American markets, they focus on industries keen to optimize their manufacturing processes through biocatalysis solutions. Hephaistos generates revenue through strategic partnerships and B2B transactions with clients in the chemical manufacturing sector.

The company's business model centers around providing customized enzyme solutions, which may involve tailored contracts for enzyme development and validation processes. Clients engage with Hephaistos through direct collaborations, where specific project requirements are discussed, and pricing plans are established based on the complexity and scope of the enzyme development needed. Revenue is derived from the successful delivery of these enzyme products and subsequent validation services, creating a sustainable revenue stream that supports ongoing research and development efforts. Through these engagements, Hephaistos positions itself as a pivotal partner in advancing sustainable chemical manufacturing technologies.

In June 2026, Hephaistos raised CHF 150,000 in venture funding from new investor Venture Kick. The company plans to utilize this funding for additional enzyme design campaigns, expand laboratory automation, and support initial hiring. These initiatives aim to enhance the development of new products and explore opportunities in new markets, further solidifying its position in sustainable chemical manufacturing.